
Erasca Faces Securities Lawsuit Over Oncology Drug Claims
Investors who purchased Erasca, Inc. common stock between January 14, 2025, and April 26, 2026, face an August 10, 2026, deadline to serve as lead plaintiff in a pending securities class action lawsuit filed by the Rosen Law Firm.




























